Malignant neoplasm of pancreas
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
NT-3 protein expression was then studied in 47 human pancreatic cancers, using a monoclonal antibody against human NT-3 protein.
|
9196438 |
1997 |
Coronary Arteriosclerosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
We also identify SORT1 and CELSR2 as candidate susceptibility genes for a locus recently associated with coronary artery disease and plasma low-density lipoprotein cholesterol levels in the process.
|
18462017 |
2008 |
Coronary Artery Disease
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
We also identify SORT1 and CELSR2 as candidate susceptibility genes for a locus recently associated with coronary artery disease and plasma low-density lipoprotein cholesterol levels in the process.
|
18462017 |
2008 |
Coronary heart disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We also identify SORT1 and CELSR2 as candidate susceptibility genes for a locus recently associated with coronary artery disease and plasma low-density lipoprotein cholesterol levels in the process.
|
18462017 |
2008 |
Adenoma
|
0.020 |
AlteredExpression
|
group |
BEFREE |
NTR3 mRNA expression was observed in all examined samples and was higher in the adenomas, both functioning and nonfunctioning, compared to normal pituitary.
|
18624930 |
2008 |
Adenoma
|
0.020 |
Biomarker
|
group |
LHGDN |
NTR3 mRNA expression was observed in all examined samples and was higher in the adenomas, both functioning and nonfunctioning, compared to normal pituitary.
|
18624930 |
2008 |
Obesity
|
0.090 |
AlteredExpression
|
disease |
BEFREE |
Sortilin, an essential player in adipocyte and muscle glucose metabolism through the control of GLUT4 localisation, is downregulated in obesity and TNF-alpha is likely to be involved in this defect.
|
19219422 |
2009 |
Coronary Arteriosclerosis
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Genetic variation at chromosome 1p13.3 affects sortilin mRNA expression, cellular LDL-uptake and serum LDL levels which translates to the risk of coronary artery disease.
|
19660754 |
2010 |
Coronary Artery Disease
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Genetic variation at chromosome 1p13.3 affects sortilin mRNA expression, cellular LDL-uptake and serum LDL levels which translates to the risk of coronary artery disease.
|
19660754 |
2010 |
Coronary heart disease
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Genetic variation at chromosome 1p13.3 affects sortilin mRNA expression, cellular LDL-uptake and serum LDL levels which translates to the risk of coronary artery disease.
|
19660754 |
2010 |
Coronary Artery Disease
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The rs599839 polymorphism A/G in the vicinity of the sortilin 1 gene has been reported to be associated with low density lipoprotein cholesterol (LDL-C) and coronary artery disease (CAD).
|
19837406 |
2010 |
Myocardial Infarction
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
Association of the single nucleotide polymorphism rs599839 in the vicinity of the sortilin 1 gene with LDL and triglyceride metabolism, coronary heart disease and myocardial infarction. The Ludwigshafen Risk and Cardiovascular Health Study.
|
19837406 |
2010 |
Hypercholesterolemia
|
0.030 |
Biomarker
|
disease |
BEFREE |
Absence of sortilin in gene-targeted mice reduces secretion of lipoproteins from the liver and ameliorates hypercholesterolemia and atherosclerotic lesion formation in LDL receptor-deficient animals.
|
20816088 |
2010 |
Atherosclerotic lesion
|
0.020 |
Biomarker
|
disease |
BEFREE |
Absence of sortilin in gene-targeted mice reduces secretion of lipoproteins from the liver and ameliorates hypercholesterolemia and atherosclerotic lesion formation in LDL receptor-deficient animals.
|
20816088 |
2010 |
Myocardial Infarction
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
An accompanying study in Nature identified SORT1 as the causal gene at the 1p13 locus and showed that increased expression of sortilin-1 protein in liver was associated with lower LDL-C levels and a reduced risk of myocardial infarction.
|
20826839 |
2010 |
Frontotemporal dementia
|
0.020 |
Biomarker
|
disease |
BEFREE |
Sortilin-mediated PGRN endocytosis is likely to play a central role in FTLD-TDP pathophysiology.
|
21092856 |
2010 |
Alzheimer's Disease
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Our initial studies revealed increased levels of sortilin in post-mortem brain tissue of AD patients and that overexpression of sortilin leads to increased BACE1-mediated cleavage of APP in cultured cells.
|
21245145 |
2011 |
Alzheimer disease, familial, type 3
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Our initial studies revealed increased levels of sortilin in post-mortem brain tissue of AD patients and that overexpression of sortilin leads to increased BACE1-mediated cleavage of APP in cultured cells.
|
21245145 |
2011 |
Neurodegenerative Disorders
|
0.050 |
Biomarker
|
group |
BEFREE |
Massively parallel sequencing and splicing-sensitive junction arrays revealed that levels of 601 mRNAs were changed (including Fus (Tls), progranulin and other transcripts encoding neurodegenerative disease-associated proteins) and 965 altered splicing events were detected (including in sortilin, the receptor for progranulin) following depletion of TDP-43 from mouse adult brain with antisense oligonucleotides.
|
21358643 |
2011 |
Coronary Arteriosclerosis
|
0.400 |
Biomarker
|
disease |
CTD_human |
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease.
|
21378990 |
2011 |
Coronary Artery Disease
|
0.400 |
Biomarker
|
disease |
CTD_human |
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease.
|
21378990 |
2011 |
Myocardial Infarction
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
Our results establish two SNPs, rs17465637 in MIA3 and rs599839 near SORT1 as significant risk factors for MI in the American Genebank Caucasian population.
|
21463265 |
2011 |
Coronary heart disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
SORT1 rs599839 was associated with CHD risk (OR 1.20; 1.15-1.26) as well as total- and LDL-cholesterol, and apolipoprotein B. ANGPTL3 rs12042319 was associated with CHD risk (OR 1.11; 1.03, 1.19), total- and LDL-cholesterol, triglycerides, and interleukin-6.
|
21804106 |
2012 |
Colorectal Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
In contrast to BDNF, exogenous pro-BDNF induced CRC apoptosis, which suggests that a counterbalance mechanism is involved in the control of CRC cell survival, through sortilin as the co-receptor for p75(NTR), the high affinity receptor for pro-neurotrophins.
|
21966426 |
2011 |
Malignant neoplasm of breast
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
These data reveal the existence of an autocrine loop stimulated by proNGF and mediated by TrkA and sortilin, with the activation of Akt and Src, for the stimulation of breast cancer cell invasion.
|
22128158 |
2012 |